(令和7年5月28日)塩野義製薬株式会社による鳥居薬品株式会社等の医薬事業の統合に関する審査結果について | 公正取引委員会
https://www.jftc.go.jp/houdou/pressrelease/2025/may/250528kiketesu_st.html(令和7年5月28日)塩野義製薬株式会社による鳥居薬品株式会社等の医薬事業の統合に関する審査結果について | 公正取引委員会
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces the Fair Trade Commission's examination results regarding Shionogi Pharmaceutical's acquisition of Torii Pharmaceutical and Japan Tobacco's pharmaceutical business division, released May 28, 2025. After reviewing filings under the Antimonopoly Act, the FTC determined that the integration would not substantially restrict competition in relevant markets, provided the companies implement proposed remedial measures. Consequently, no cease-and-desist order was issued. Detailed examination results are available in supplementary materials.
